Jeffrey L. Wade
2022
In 2022, Jeffrey L. Wade earned a total compensation of $2M as President and Chief Financial Officer at Lexicon Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $260,075 |
|---|---|
| Option Awards | $843,690 |
| Salary | $513,354 |
| Stock Awards | $357,824 |
| Other | $15,220 |
| Total | $1,990,163 |
Wade received $843.7K in option awards, accounting for 42% of the total pay in 2022.
Wade also received $260.1K in bonus, $513.4K in salary, $357.8K in stock awards and $15.2K in other compensation.
Rankings
In 2022, Jeffrey L. Wade's compensation ranked 1,756th out of 5,760 executives tracked by ExecPay. In other words, Wade earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,756 out of 5,760 | 70th |
Division Manufacturing | 918 out of 3,136 | 71st |
Major group Chemicals And Allied Products | 372 out of 1,422 | 74th |
Industry group Drugs | 340 out of 1,323 | 74th |
Industry Pharmaceutical Preparations | 244 out of 969 | 75th |
Source: SEC filing on March 26, 2024.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2022.
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019